The medtech industry’s No. 1 player, Medtronic, is the focus of this edition of Device Week, as the firm hit the headlines with some impressive first fiscal quarter results and positive data from a trial of its Synchromed II drug infusion pump. Medtech Insight’s Reed Miller and Tina Tan chat about what helped to boost the company’s top- and bottom-lines and delve deeper into the SISTERS trial for Synchromed and the impact these results will have on the company’s pain management business.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode:
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
